FDA data Registry peer set 3 peers

Alternatives to semaglutide

3 same-class SPL records vs semaglutide - uses, FAERS reaction fields, and OTC/Rx flags from public FDA sources.

Brand: Ozempic, Wegovy, Rybelsus

GLP-1 Receptor Agonist Prescription 3 alternatives found

How to read a high-report FAERS peer set

semaglutide ranks in the upper FAERS-volume third of the corpus (#102 of 524); 3 same-class peers are listed for field comparison only. Labeled indication field for semaglutide: Ozempic is used to improve blood sugar control in adults with type 2 diabetes, along with diet and exercise.

Top FAERS reaction fields for semaglutide total 48,346 reports across 10 reactions, set beside dulaglutide, exenatide, liraglutide. Counts are exposure-weighted submissions, not per-patient risk.

About semaglutide

Ozempic is a medicine that helps lower blood sugar in adults with type 2 diabetes. It can also lower the risk of heart problems in adults with both type 2 diabetes and heart disease.

Used for: Ozempic is used to improve blood sugar control in adults with type 2 diabetes, along with diet and exercise. It can also reduce the risk of major heart problems like heart attack, stroke, or death in adults who have both type 2 diabetes and heart disease. Ozempic has not been studied in patients with a history of pancreatitis, so other diabetes medicines may be better for you.

3 GLP-1 Receptor Agonist peers (wide set)

Compare semaglutide vs dulaglutide side-by-side →

semaglutide vs dulaglutide & exenatide · FAERS reaction fields

FAERS top-reaction field "Constipation" shows the widest count spread between semaglutide and dulaglutide, exenatide, liraglutide in this extract (2,309-report gap on that field). Counts are exposure-weighted submissions, not prevalence rates.

Side Effect semaglutide dulaglutideexenatideliraglutide
Nausea 10,666 9,986 12,040 7,005
Vomiting 6,913 5,413 4,345 3,364
Diarrhoea 6,093 5,737 2,742 3,263
Decreased Appetite 4,428 3,153 5,643 2,066
Constipation 4,344 2,035 - 1,492
Weight Decreased 3,931 3,349 12,125 2,076
Fatigue 3,312 2,409 1,759 1,635
Headache 3,156 - 2,086 1,988

"-" means no reports for that reaction. Report counts reflect total FAERS submissions, not prevalence rates.

semaglutide FAERS volume vs class peers

FAERS volume band

semaglutide is FAERS corpus rank #102 of 524 (high volume tercile). Top-reaction field total: 48,346.

Frequently Asked Questions

Where does semaglutide sit in FAERS report volume vs GLP-1 Receptor Agonist peers?
semaglutide ranks #102 of 524 drugs by FAERS top-reaction report volume (high volume tercile). Top-reaction fields total 48,346 submissions in this extract, exposure-weighted counts, not per-patient risk.

Registry note: FAERS counts are voluntary reports and do not establish causation or risk rates. This information is for educational purposes only and is not a substitute for professional medical advice. Do not stop or change your medication without talking to your doctor or pharmacist.

Full semaglutide profile →

Field note for semaglutide: see also the generic vs brand label guide when reading Ozempic SPL strings.